Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400011-JLR200

Scavenger receptors were originally defined by their ability to bind and internalize modified lipoproteins. Macrophages express at least six structurally different cell surface receptors for modified forms of LDL that contribute to foam cell formation in atherosclerosis. In addition to their role in the pathology of atherosclerosis, macrophage scavenger receptors, especially SR-A, play critical roles in innate immunity, apoptotic cell clearance, and tissue homeostasis. In this review, we highlight recent advances in understanding the biology of macrophage scavenger receptors as pattern recognition receptors for both infectious nonself (pathogens) and modified self (apoptotic cells and modified LDL). We critically evaluate the potential of scavenger receptors and their ligands as targets for therapeutic intervention in human disease.

[1]  U. Holmskov,et al.  The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. , 2004, Critical reviews in immunology.

[2]  Alan S. Brown,et al.  Statin use in acute coronary syndromes: cellular mechanisms and clinical evidence , 2002, Current opinion in lipidology.

[3]  S. Sims,et al.  Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. , 1999, Circulation research.

[4]  R. Medzhitov,et al.  Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.

[5]  D. Steinberg.  Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis? , 2000, Current opinion in lipidology.

[6]  N. Dohmae,et al.  Type F Scavenger Receptor SREC-I Interacts with Advillin, a Member of the Gelsolin/Villin Family, and Induces Neurite-like Outgrowth* , 2004, Journal of Biological Chemistry.

[7]  松下 紀子.  Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3 , 2003 .

[8]  友清 龍一郎.  Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors , 2002 .

[9]  T. Kita,et al.  Cutting Edge: SR-PSOX/CXC Chemokine Ligand 16 Mediates Bacterial Phagocytosis by APCs Through its Chemokine Domain1 , 2003, The Journal of Immunology.

[10]  M. Tsujimoto,et al.  FEEL-1, a Novel Scavenger Receptor with in Vitro Bacteria-binding and Angiogenesis-modulating Activities* , 2002, The Journal of Biological Chemistry.

[11]  S. M. Sims,et al.  Innate Diversity of Adult Human Arterial Smooth Muscle Cells: Cloning of Distinct Subtypes From the Internal Thoracic Artery , 2001, Circulation research.

[12]  D. Steinberg,et al.  Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors. , 2000, Journal of lipid research.

[13]  E. Dennis,et al.  The Binding of Oxidized Low Density Lipoprotein to Mouse CD36 Is Mediated in Part by Oxidized Phospholipids That Are Associated with Both the Lipid and Protein Moieties of the Lipoprotein* , 2000, The Journal of Biological Chemistry.

[14]  K. Tryggvason,et al.  The Scavenger Receptor MARCO Is Required for Lung Defense against Pneumococcal Pneumonia and Inhaled Particles , 2004, The Journal of experimental medicine.

[15]  H. Arai,et al.  Expression Cloning of a Novel Scavenger Receptor from Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[16]  T. Kodama,et al.  The Class A Macrophage Scavenger Receptor Is a Major Pattern Recognition Receptor for Neisseria meningitidis Which Is Independent of Lipopolysaccharide and Not Required for Secretory Responses , 2002, Infection and Immunity.

[17]  Andreas Lengeling,et al.  The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal , 2004, Journal of biology.

[18]  C. H. Liu,et al.  Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. , 1996, Circulation.

[19]  T. Sawamura,et al.  LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. , 2002, Pharmacology & therapeutics.

[20]  R. Silverstein,et al.  A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.

[21]  S. Epstein,et al.  Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. , 1996, The Journal of clinical investigation.

[22]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[23]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[24]  R. Evans,et al.  PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. , 1998, Cell.

[25]  G. Silverman,et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.

[26]  T. Kita,et al.  Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. , 2001, Trends in cardiovascular medicine.

[27]  P. Connell,et al.  SR-BII, an Isoform of the Scavenger Receptor BI Containing an Alternate Cytoplasmic Tail, Mediates Lipid Transfer between High Density Lipoprotein and Cells* , 1998, The Journal of Biological Chemistry.

[28]  S. Ogawa,et al.  Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. , 2004, DNA and cell biology.

[29]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.

[30]  T. Kodama,et al.  Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Krieger,et al.  Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). , 1994, Annual review of biochemistry.

[32]  K. Moore,et al.  Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.

[33]  Simon C Watkins,et al.  A Role for Class A Scavenger Receptor in Dendritic Cell Nibbling from Live Cells1 , 2003, The Journal of Immunology.

[34]  K. Tryggvason,et al.  Arginine residues in domain V have a central role for bacteria-binding activity of macrophage scavenger receptor MARCO. , 2002, Biochemical and biophysical research communications.

[35]  ToruKita,et al.  Ligand Specificity of LOX-1, a Novel Endothelial Receptor for Oxidized Low Density Lipoprotein , 1998 .

[36]  D. Jackson,et al.  Rapid Plasma Membrane-Endosomal Trafficking of the Lymph Node Sinus and High Endothelial Venule Scavenger Receptor/Homing Receptor Stabilin-1 (Feel-1/Clever-1)* , 2004, Journal of Biological Chemistry.

[37]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[38]  S. Goerdt,et al.  Stabilin‐1 localizes to endosomes and the trans‐Golgi network in human macrophages and interacts with GGA adaptors , 2004, Journal of leukocyte biology.

[39]  M. Linton,et al.  Inactivation of Macrophage Scavenger Receptor Class B Type I Promotes Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice , 2003, Circulation.

[40]  A. Tall,et al.  Decreased Atherosclerosis in Heterozygous Low Density Lipoprotein Receptor-deficient Mice Expressing the Scavenger Receptor BI Transgene* , 1999, The Journal of Biological Chemistry.

[41]  R. Silverstein,et al.  Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[42]  S. Gordon,et al.  Monocyte heterogeneity and innate immunity. , 2003, Immunity.

[43]  T. Kita,et al.  Chemokines Generally Exhibit Scavenger Receptor Activity through Their Receptor-binding Domain* , 2004, Journal of Biological Chemistry.

[44]  S. Miyamoto,et al.  Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. , 1999, Circulation.

[45]  M. Krieger,et al.  Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.

[46]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[47]  D. Silver.  A Carboxyl-terminal PDZ-interacting Domain of Scavenger Receptor B, Type I Is Essential for Cell Surface Expression in Liver* , 2002, The Journal of Biological Chemistry.

[48]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[49]  M. Dierich,et al.  Cutting Edge: Productive HIV-1 Infection of Dendritic Cells via Complement Receptor Type 3 (CR3, CD11b/CD18) , 2004, The Journal of Immunology.

[50]  T. Willson,et al.  Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. , 2000, The Journal of clinical investigation.

[51]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[52]  D. Ory.  Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? , 2004, Circulation research.

[53]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[54]  Masashi Komeda,et al.  Expression of SR-PSOX, a Novel Cell-Surface Scavenger Receptor for Phosphatidylserine and Oxidized LDL in Human Atherosclerotic Lesions , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[55]  T. Nikkari,et al.  Macrophage foam cells from human aortic fatty streaks take up beta-VLDL and acetylated LDL in primary culture. , 1989, Atherosclerosis.

[56]  S. Joseph,et al.  LXRs: new therapeutic targets in atherosclerosis? , 2003, Current opinion in pharmacology.

[57]  S. Gordon,et al.  A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. , 1998, Journal of lipid research.

[58]  M. Freeman,et al.  Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.

[59]  J. Breslow,et al.  Intracellular Cholesterol Transport , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[60]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[61]  Yijun Deng,et al.  Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36* , 2002, The Journal of Biological Chemistry.

[62]  T. Kita,et al.  Expression of lectin‐like oxidized low density lipoprotein receptor‐1 in human and murine macrophages: upregulated expression by TNF‐α , 1998, FEBS letters.

[63]  Andrew C. Li,et al.  The macrophage foam cell as a target for therapeutic intervention , 2002, Nature Medicine.

[64]  T. Kodama,et al.  The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock , 1997, The Journal of experimental medicine.

[65]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[66]  H. Hydén,et al.  A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .

[67]  R. Wait,et al.  Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP‐3 , 2002, Clinical and experimental immunology.

[68]  U. Hedin,et al.  CXCL16/SR-PSOX Is an Interferon-&ggr;–Regulated Chemokine and Scavenger Receptor Expressed in Atherosclerotic Lesions , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[69]  M. Krieger,et al.  The SRCR superfamily: a family reminiscent of the Ig superfamily. , 1994, Trends in biochemical sciences.

[70]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[71]  村瀬 孝利.  Identification of soluble forms of lectin-like oxidized LDL receptor-1 , 2004 .

[72]  T. Kita,et al.  Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages* , 2000, The Journal of Biological Chemistry.

[73]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[74]  Y. Kurihara,et al.  Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. , 1993, The Journal of biological chemistry.

[75]  D. Steinberg,et al.  Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[76]  T. Hayek,et al.  Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes. , 2002, Atherosclerosis.

[77]  M. Krieger,et al.  Loss of SR-BI Expression Leads to the Early Onset of Occlusive Atherosclerotic Coronary Artery Disease, Spontaneous Myocardial Infarctions, Severe Cardiac Dysfunction, and Premature Death in Apolipoprotein E-Deficient Mice , 2002, Circulation research.

[78]  D. Steinberg,et al.  The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[79]  Hiroshi Suzuki,et al.  Scavenger Receptor Expressed by Endothelial Cells I (SREC-I) Mediates the Uptake of Acetylated Low Density Lipoproteins by Macrophages Stimulated with Lipopolysaccharide* , 2004, Journal of Biological Chemistry.

[80]  N. Andrews,et al.  Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  S. Pizzo,et al.  SREC-I, a Type F Scavenger Receptor, Is an Endocytic Receptor for Calreticulin* , 2004, Journal of Biological Chemistry.

[82]  S. Vogel,et al.  Identification of Small PDZK1-associated Protein, DD96/MAP17, as a Regulator of PDZK1 and Plasma High Density Lipoprotein Levels* , 2003, Journal of Biological Chemistry.

[83]  S. Gordon,et al.  The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. , 2001, Microbes and infection.

[84]  R. P. D. Silva,et al.  Membrane molecules and macrophage endocytosis: scavenger receptor and macrosialin as markers of plasma-membrane and vacuolar functions. , 1996, Biochemical Society transactions.

[85]  C. Glass,et al.  PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[86]  C. Glass,et al.  Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[87]  M. Freeman,et al.  Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. , 1990, Nature.

[88]  S. Hazen,et al.  A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions* , 2002, Journal of Biological Chemistry.

[89]  Scott D Covey,et al.  Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[90]  H. Shimano,et al.  FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products* , 2003, The Journal of Biological Chemistry.

[91]  I. Wickelgren.  Gene Suggests Asthma Drugs May Ease Cardiovascular Inflammation , 2004, Science.

[92]  O. Kallioniemi,et al.  Lipoprotein uptake in primary cell cultures of rabbit atherosclerotic lesions. A fluorescence microscopic and flow cytometric study. , 1988, Atherosclerosis.

[93]  S. Moestrup,et al.  Identification of the haemoglobin scavenger receptor , 2001, Nature.

[94]  S. Goerdt,et al.  Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. , 2002, The Biochemical journal.

[95]  K. Moore,et al.  CD36 Mediates the Innate Host Response to β-Amyloid , 2003, The Journal of experimental medicine.

[96]  T Kita,et al.  Biosynthesis and Post-translational Processing of Lectin-like Oxidized Low Density Lipoprotein Receptor-1 (LOX-1) , 2000, The Journal of Biological Chemistry.

[97]  L. Kedzierski,et al.  A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 31 , 2004, The Journal of Immunology.

[98]  H. Lodish,et al.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.

[99]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[100]  T. Kodama,et al.  Protection from Lethal Gram-Positive Infection by Macrophage Scavenger Receptor–Dependent Phagocytosis , 2000, The Journal of experimental medicine.

[101]  M. Albert,et al.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.

[102]  S Gordon,et al.  Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[103]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[104]  R. E. Pitas,et al.  Synergistic Effects of Growth Factors on the Regulation of Smooth Muscle Cell Scavenger Receptor Activity (*) , 1995, The Journal of Biological Chemistry.

[105]  M. Krieger,et al.  Recognition and plasma clearance of endotoxin by scavenger receptors , 1991, Nature.

[106]  C. Argmann,et al.  Human Smooth Muscle Cell Subpopulations Differentially Accumulate Cholesteryl Ester When Exposed to Native and Oxidized Lipoproteins , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[107]  B. Seed,et al.  PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. , 1998, Nature.

[108]  L. Rohrer,et al.  The type I and type II bovine scavenger receptors expressed in Chinese hamster ovary cells are trimeric proteins with collagenous triple helical domains comprising noncovalently associated monomers and Cys83-disulfide-linked dimers. , 1991, The Journal of biological chemistry.

[109]  T. Kodama,et al.  Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. , 2002, Atherosclerosis.

[110]  H. Robenek,et al.  Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[111]  M. Boaz,et al.  Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.

[112]  A. Tall,et al.  Tangier disease as a test of the reverse cholesterol transport hypothesis. , 2000, The Journal of clinical investigation.

[113]  P. Connell,et al.  Alternative forms of the scavenger receptor BI (SR-BI). , 1997, Journal of lipid research.

[114]  S. Gordon,et al.  Activation of murine macrophages by Neisseria meningitidis and IFN‐γ in vitro: distinct roles of class A scavenger and Toll‐like pattern recognition receptors in selective modulation of surface phenotype , 2004, Journal of leukocyte biology.

[115]  A. Rigotti,et al.  Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism* , 2003, Journal of Biological Chemistry.

[116]  S. Gordon,et al.  Scavenger receptors in innate immunity. , 2002, Current opinion in immunology.

[117]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[118]  T. V. van Berkel,et al.  Scavenger Receptor Classes A and B: Their Roles in Atherogenesis and the Metabolism of Modified LDL and HDL , 2000, Annals of the New York Academy of Sciences.

[119]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[120]  M. Freeman,et al.  The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. , 1993, The Journal of biological chemistry.

[121]  Andrew C. Li,et al.  Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice , 2000 .

[122]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[123]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque , 1984, Arteriosclerosis.

[124]  E. Fisher,et al.  Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[125]  I. Thesleff,et al.  Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages , 1995, Cell.

[126]  R. E. Pitas,et al.  Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblasts. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[127]  M. Freeman.  Macrophage scavenger receptors. , 1994, Current opinion in lipidology.

[128]  J. Fawcett,et al.  Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. , 1993, The Journal of biological chemistry.

[129]  A. Levy,et al.  Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease , 2003, Circulation research.

[130]  S. Lorkowski,et al.  Laser Microdissection-based Analysis of mRNA Expression in Human Coronary Arteries with Intimal Thickening , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[131]  D. Rader,et al.  Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[132]  S. Goerdt,et al.  Stabilin-1 and −2 constitute a novel family of fasciclin-like hyaluronan receptor homologues , 2002 .

[133]  O. Francone.  SR-BI: a new player in an old game. , 2003, Arteriosclerosis, thrombosis, and vascular biology.